Wednesday, March 20, 2019

Pure Omega-3 prescription drug markedly reduces first, repeat and total CV events: New data show 4 gram dose of icosapent ethyl may be new, cost-effective way to prevent CV complications among patients with elevated triglycerides who have heart disease or diabetes - Science Daily

  1. Pure Omega-3 prescription drug markedly reduces first, repeat and total CV events: New data show 4 gram dose of icosapent ethyl may be new, cost-effective way to prevent CV complications among patients with elevated triglycerides who have heart disease or diabetes  Science Daily
  2. Amarin's Vascepa Cuts Heart Attack and Stroke Risk by 30%  BioSpace
  3. Research: Pure omega-3 prescription drug significantly reduces the occurrence of ischemic events  News-Medical.net
  4. Vascepa® (icosapent ethyl) Showed 30% Reduction in Total Cardiovascular Events Including Recurrent Events in REDUCE-IT™  PRNewswire
  5. Omega 3 fatty acid prescription pill lowers heart attack risk by 30%  Specialty Medical Dialogues
  6. View full coverage on Google News
(CLICK HERE TO READ AND SEE MORE

0 comments:

Post a Comment